文献速递贫血与红细胞疾病

VEXAS贫血是一种嵌合性红系细胞减少症

VEXAS anemia is a mosaic erythroblastopenia.
PubMed 文献 · Blood · 2026-01-01

本研究结合VEXAS综合征患者成熟红细胞与骨髓红系细胞的体内评估及红系生成的体外碱基编辑模型,发现成熟红细胞无泛素化缺陷,患者骨髓红系细胞在嗜碱性阶段后缺乏UBA1突变;体外编辑UBA1变体导致早期红系分化高死亡率及TP53过表达,提出VEXAS贫血应视为嵌合性红系细胞减少症。

要点

  • VEXAS患者成熟红细胞无泛素化缺陷,骨髓红系细胞在嗜碱性阶段后缺乏UBA1突变。
  • 体外碱基编辑UBA1变体导致早期红系分化高死亡率,但单核分化不受影响。
  • 编辑的红系前体细胞显示TP53过表达及核糖体生物合成异常,类似Diamond-Blackfan贫血。

核心结论

  • VEXAS综合征相关贫血应被视为嵌合性红系细胞减少症,贫血严重程度受UBA1野生型 compartment 的质量和数量影响。

研究设计与样本

  • 研究结合VEXAS综合征患者成熟红细胞和骨髓红系细胞的体内评估,以及红系生成的体外碱基编辑模型。

主要发现

  • 成熟红细胞不显示泛素化缺陷,患者来源的骨髓红系细胞在嗜碱性阶段后缺乏UBA1突变。
  • 体外碱基编辑CD34+原代细胞中的UBA1变体导致早期红系分化期间高死亡率,但单核细胞分化期间未出现。
  • 编辑的红系前体细胞显示与泛素化缺陷相关的TP53过表达及核糖体生物合成异常,类似Diamond-Blackfan贫血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently discovered autoinflammatory disorder linked to somatic mutations in the UBA1 gene, resulting in a profound cytoplasm-restricted defect in ubiquitylation. The disease is characterized by a macrocytic anemia that remains poorly understood. To investigate the erythroid lineage in VEXAS syndrome, we conducted a comprehensive study combining in vivo assessments of patients' mature red cells and marrow erythroblasts, alongside in vitro base-editing models of erythropoiesis. Here, we show that mature red cells do not exhibit ubiquitylation defects, and patient-derived bone marrow erythroblasts lack UBA1 mutations beyond the basophilic stage of erythroid differentiation. In vitro base editing of UBA1 variants in CD34+ primary cells resulted in high mortality during early erythroid differentiation but not during monocytic differentiation. Edited erythroid precursors displayed TP53 overexpression linked to defective ubiquitylation and anomalies in ribosome biogenesis, reminiscent of Diamond-Blackfan anemia. We propose that VEXAS syndrome-associated anemia should be considered as a mosaic erythroblastopenia, in which the severity of anemia is influenced by the quality and quantity of the UBA1-wild-type compartment. Our findings offer new insights into the physiopathology of VEXAS syndrome and may suggest new potential therapeutic options.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Rodrigues F, Hardouin G, El Hoss S, et al. VEXAS anemia is a mosaic erythroblastopenia. Blood. 2026. PMID: 40971475. doi:10.1182/blood.2025029081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。